Lord, Abbett & Co’s Mirum Pharmaceuticals MIRM Stock Holding History

Lord, Abbett & Co’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63.3M	Sell	540,977 -76,087	-12%	-$7.64M	0.18%	145
2026 Q1	$57M	Buy	617,064 +37,081	+6%	+$3.49M	0.19%	145
2025 Q4	$45.8M	Sell	579,983 -81,957	-12%	-$5.88M	0.14%	177
2025 Q3	$48.5M	Sell	661,940 -109,206	-14%	-$6.94M	0.14%	168
2025 Q2	$39.2M	Sell	771,146 -42,252	-5%	-$1.88M	0.13%	192
2025 Q1	$36.6M	Buy	813,398 +31,044	+4%	+$1.46M	0.13%	191
2024 Q4	$32.4M	Buy	782,354 +40,986	+6%	+$1.71M	0.1%	240
2024 Q3	$28.9M	Buy	+741,368	New	+$29.6M	0.09%	265

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co's MIRM Position: Q2 2026 in Review

Lord, Abbett & Co reduced its Mirum Pharmaceuticals (MIRM) stake by 12% in Q2 2026, selling an estimated $7.64M and leaving 540,977 shares worth $63.3M. The position accounts for 0.18% of the portfolio, ranked #145.

Lord, Abbett & Co first reported a position in MIRM in Q3 2024 and has held it in 8 quarters since. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Lord, Abbett & Co held 540,977 shares of Mirum Pharmaceuticals worth $63.3M as of Q2 2026.
Lord, Abbett & Co sold 76,087 Mirum Pharmaceuticals shares in Q2 2026, an estimated $7.64M.
Mirum Pharmaceuticals made up 0.18% of Lord, Abbett & Co's portfolio in Q2 2026, its #145 holding.
Lord, Abbett & Co first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.